Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Slavin, Shimon; Nagler, Arnon; Naparstek, E; Kapelushnik, Y.; Aker, Memet; Cividalli, Gabriel; Varadi, Gàbor; Kirschbaum, Mark; Ackerstein, Aliza; Samuel, Simcha; Amar, Avraham; Brautbar, Chaim; Ben‐Tal, Ofira; Eldor, A; Or, Reuven

doi:10.1182/blood.v91.3.756.756_756_763

Public

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Published in Blood • Feb 1, 1998

Authors:

Shimon Slavin

Arnon Nagler

E Naparstek

Abstract

Myeloablative conditioning associated with hazardous immediate and late complications is considered as a mandatory first step in preparation for allogeneic blood or marrow transplantation (allogeneic BMT) for the treatment of malignant hematologic disorders and genetic diseases. Immune-mediated graf...

Subject

Medicine

Busulfan

Fludarabine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!